Burning Rock Biotech Limited
BNR
$16.76
-$0.07-0.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -0.35% | -0.35% | -5.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -0.35% | -0.35% | -5.76% |
| Cost of Revenue | -- | -- | -13.17% | -13.17% | -13.44% |
| Gross Profit | -- | -- | 5.89% | 5.89% | -2.09% |
| SG&A Expenses | -- | -- | -41.00% | -41.00% | -35.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -35.29% | -35.29% | -31.77% |
| Operating Income | -- | -- | 65.33% | 65.33% | 52.68% |
| Income Before Tax | -- | -- | 60.67% | 60.67% | 48.61% |
| Income Tax Expenses | -- | -- | 175.52% | 175.52% | 143.77% |
| Earnings from Continuing Operations | -- | -- | 59.81% | 59.81% | 47.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 59.81% | 59.81% | 47.91% |
| EBIT | -- | -- | 65.33% | 65.33% | 52.68% |
| EBITDA | -- | -- | 75.14% | 75.14% | 62.06% |
| EPS Basic | -- | -- | 60.12% | 60.12% | 48.13% |
| Normalized Basic EPS | -- | -- | 85.01% | 85.01% | 70.21% |
| EPS Diluted | -- | -- | 60.12% | 60.12% | 48.13% |
| Normalized Diluted EPS | -- | -- | 85.01% | 85.01% | 70.21% |
| Average Basic Shares Outstanding | -- | -- | 1.72% | 1.72% | 0.52% |
| Average Diluted Shares Outstanding | -- | -- | 1.72% | 1.72% | 0.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |